| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 435 |
| 1 | FLUDARABINE PHOSPHATE | 237 |
| 2 | VENETOCLAX | 211 |
| 3 | IBRUTINIB | 122 |
| 4 | CYCLOPHOSPHAMIDE | 115 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 115 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 115 |
| 7 | OBINUTUZUMAB | 84 |
| 8 | BENDAMUSTINE HCL | 61 |
| 9 | IDELALISIB | 54 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PIRTOBRUTINIB | 12 | 0.0122 |
| 1 | CHLORAMBUCIL | 33 | 0.0084 |
| 2 | IDELALISIB | 54 | 0.0077 |
| 3 | FLUDARABINE PHOSPHATE | 237 | 0.0059 |
| 4 | PENTOSTATIN | 6 | 0.0057 |
| 5 | OBINUTUZUMAB | 84 | 0.0050 |
| 6 | BENDAMUSTINE HCL | 61 | 0.0039 |
| 7 | RASBURICASE | 9 | 0.0036 |
| 8 | VENETOCLAX | 211 | 0.0034 |
| 9 | ACALABRUTINIB | 36 | 0.0028 |
| # | Drug class | Count |
|---|---|---|
| 0 | CD20-directed Cytolytic Antibody [EPC] | 478 |
| 1 | BCL-2 Inhibitor [EPC] | 211 |
| 2 | Kinase Inhibitor [EPC] | 192 |
| 3 | Alkylating Drug [EPC] | 134 |
| 4 | Corticosteroid [EPC] | 79 |
| 5 | Xanthine Oxidase Inhibitor [EPC] | 36 |
| 6 | CD52-directed Cytolytic Antibody [EPC] | 22 |
| 7 | Leukocyte Growth Factor [EPC] | 21 |
| 8 | Vitamin C [EPC] | 20 |
| 9 | Azole Antifungal [EPC] | 18 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | BCL-2 Inhibitor [EPC] | 211 | 0.0034 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 478 | 0.0015 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 22 | 0.0011 |
| 3 | Alkylating Drug [EPC] | 134 | 0.0005 |
| 4 | Thrombopoietin Receptor Agonist [EPC] | 8 | 0.0005 |
| 5 | Human Immunoglobulin G [EPC] | 10 | 0.0005 |
| 6 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 7 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 8 | Provitamin D2 Compound [EPC] | 12 | 0.0004 |
| 9 | Kinase Inhibitor [EPC] | 192 | 0.0003 |